MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2025.133273

Медицинская библиотека · International journal of cardiology · 2025

Long term prognosis in cardiac sarcoidosis under FDG-PET guided immunosuppressive therapy.

Imamura Yasutaka, Momose Mitsuru, Yamamoto Atsushi, Suzuki Atsushi, Serizawa Naoki, Uto Kenta, Watanabe Eri, Nagao Michinobu, Sakai Shuji, Yamaguchi Junichi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cardiac sarcoidosis (CS) is a granulomatous disease that can lead to heart failure and fatal arrhythmias. While 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is useful in assessing active inflammation, its role in guiding immunosuppressive therapy and predicting long-term prognosis remains unclear.

METHODS

This retrospective study analyzed 36 CS patients who underwent FDG-PET-guided immunosuppressive therapy between 2012 and 2017. FDG uptake was quantitatively evaluated before treatment, at 6 and 12 months, and annually thereafter. Prognostic outcomes, including major adverse cardiac events (MACE) and mortality, were assessed.

RESULTS

Over a median follow-up of 8.2 years, 11 patients experienced MACE, and 7 died. SUVmax at 6 months (six-M SUVmax) and 1 year (one-y SUVmax) significantly correlated with prognosis. Patients with one-y SUVmax >4.5 had a higher risk of adverse events (p < 0.0001), while patients with six-M SUVmax >3.5 had a higher risk of adverse events (p = 0.035). Lower left ventricular ejection fraction (LVEF <40 %) was also associated with worse outcomes. Those requiring a final prednisolone (PSL) dose ≥10 mg had increased mortality (p < 0.0001).

CONCLUSION

FDG-PET-derived SUVmax at 1 year is a critical prognostic indicator in CS patients undergoing immunosuppressive therapy. Poor response to PSL, indicated by persistent FDG uptake, correlates with worse outcomes. Regular FDG-PET monitoring and personalized treatment strategies are essential to optimizing long-term management.

Для цитирования: Imamura Yasutaka, Momose Mitsuru, Yamamoto Atsushi, Suzuki Atsushi, Serizawa Naoki, Uto Kenta, Watanabe Eri, Nagao Michinobu, Sakai Shuji, Yamaguchi Junichi. Long term prognosis in cardiac sarcoidosis under FDG-PET guided immunosuppressive therapy.. International journal of cardiology. 2025. DOI: 10.1016/j.ijcard.2025.133273.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.